The hematopoietic stem cells present in the umbilical cord blood and the mesenchymal stem cells present in the cord tissue and placenta belong to the group of multipotent stem cells.
The Bioscience Institute offers the option of conserving both umbilical cord blood stem cells and cord tissue stem cells.
Umbilical cord blood stem cells can be stored for the newborn or for allogeneic use by compatible family members.
More than 40,000 transplants of stem cells from umbilical cord carried out around the world for the treatment of many diseases confirm the importance and scientific validity of preservation(1).
1. Ballen KK et al. Umbilical cord blood transplantation: the first 25 years and beyond. Blood. 2013 Jul 25;122(4):491-8. doi: 10.1182/blood-2013-02-453175
The preservation of a segment of cord tissue collected at the time of delivery is carried out by the Bioscience Institute upon request by its customers.
From Wharton’s jelly, a substance present in the cord tissue, it is possible to isolate adult mesenchymal stem cells. These are stem cells that differ from those of cord blood in terms of characteristics and potential for therapeutic use.
Cord blood is the blood that remains in the umbilical cord after the baby is born and is a valuable source of stem cells.
Until recently it was treated as “waste” and eliminated with hospital waste along with the placenta and the umbilical cord. It is currently used in the treatment of around 100 serious diseases.
